ÂÜÀòÂÒÂ×

Howard Bleichfeld is an attorney with a diverse range of experience in the pharmaceutical and legal sectors. Howard is currently the Director of Clinical Contracts Counsel at ImmunoGen, Inc. since April 2022. Prior to this role, they worked at Acceleron Pharma Inc. as an Associate Director of Contracts Counsel from March 2021 to March 2022, and at Apellis Pharmaceuticals as Counsel, Clinical from June 2020 to March 2021. From April 2018 to January 2020, Howard served as a Corporate Counsel at Sunovion Pharmaceuticals. Prior to their work in the pharmaceutical industry, Howard held roles as Counsel, North America at Alere Inc. from October 2016 to April 2018 and as an attorney at their own law firm, Howard Bleichfeld, Attorney at Law, from January 2010 to September 2016. Howard also worked as Counsel at Robinsong Ecological Resources, Inc. from 2007 to 2009. Howard began their legal career as an Attorney at Van Ness Feldman LLP where they focused on securing environmental permits and representing clients on environmental legislation from 1995 to 2007.

Howard Bleichfeld attended Cornell University and earned a Bachelor of Science (BS) degree. Howard then pursued their legal education at The George Mason University School of Law, where they obtained a Doctor of Law (JD) degree.